Biosimilars & generics
Generic and biosimilar medicines — from small molecules to insulin analogues — developed and proven against their world reference before a single box ships.
Research & development
البحث والتطوير
Science, made at home
Pharmaceutical sovereignty starts at the bench. Our scientists take the world's most-needed molecules and rebuild them for Algerian production — biosimilars and generics, same rigour, same efficacy, radically closer to the patient.
The molecule, in motion — 3D render
The research engine
From world reference to wilaya shelf
Injector pens & delivery
Robustness and real-world studies on injector pens and delivery systems, alongside solid forms and sterile injectables engineered for Saharan heat and Mediterranean humidity alike.
Analytical control
Chromatography and stability suites feed a double quality-control system — including an LNCPP-approved control lab — with QA and regulatory documentation now digitalized.
Formulation lab — Ben M'HidiBy the numbers
Science at industrial scale
- Production sites5
- Therapeutic areas9
- Units a year250M+
- People2,000+
Every launch closes one more import line — and keeps another dinar of health spending working inside Algeria.
Research with us
Universities, CHUs and international CROs — our formulation and stability labs are open to serious research partners.